RNAscopeTM technology enables faster and more rigorous target and biomarker development: it is a robust and ultra-sensitive RNA in situ hybridization (RNA ISH) method providing single-cell and single-molecule RNA detection in the context of complex tissue microenvironments.
Advanced Cell Diagnostics’ Assay Services group is the only CRO specialized in providing RNAscope, BaseScope and miRNAscope in situ hybridization (ISH) services for tissue-based and cell specific analysis of targets and biomarkers in as little as 4 weeks.
Please join us to hear how our services are contributing to and advancing the research and therapeutic development at hundreds of academic and clinical institutions in the field of immuno-oncology, neuroscience, ophthalmology, metabolic disorders, respiratory disease, and toxicological pathology.
- Visualize the cellular heterogeneity of complex organs with the multiplexing and spatial capabilities of the RNAscopeTM Multiplex Fluorescent assay
- Spatially map scRNA-seq gene profiles at the single cell level in the tissue context as well as confirm scRNA-seq results from publicly available datasets in the tissue context
- Quantifiable, single-molecule detection of biomarker RNA in fixed biopsies
- Detect splice variants, point mutations and short target sequences with BaseScope ISH assays
- Spatial mapping of stem cell markers in various tissue types such as organoids, frozen and FFPE tissues
- Localize newly identified cell subtypes and cell markers using our ISH/IHC co-detection technology
- Specific detection of engineered CAR-T and TCR-T cell therapies in clinical trial patient biopsies
- Leverage RNAscope Quality-controlled tissue bank including solid tumors, normal human tissues, and TMAs to accelerate your research
